PDE9A and cardiovascular disorder: (Baillie et al., 2019) Although expression is low in the myocardium, it is worth noting that in the PDE family, PDE9 may have the highest affinity for cGMP, especially in cardiovascular disease, where PDE9A expression is upregulated by cardiac hypertrophy and HF.